What Happens If I Only Take Mifepristone?

Taking mifepristone without following it with misoprostol starts the process of ending a pregnancy but leaves the outcome uncertain. Mifepristone on its own blocks the hormone that sustains a pregnancy, and for some people that is enough to cause a complete abortion, but for many others, the pregnancy either continues or ends only partially. The wide gap between those outcomes and the complications that can follow make this a situation worth understanding in detail.

How Mifepristone Works on Its Own

During pregnancy, progesterone keeps the uterine lining thick and stable, and it suppresses contractions that could dislodge the embryo. Mifepristone binds to the same receptors progesterone uses but does not activate them, so it effectively locks the hormone out. Once progesterone is blocked, the uterine lining begins to break down, blood vessels that supply the embryo weaken, and the uterus becomes more contractile on its own.

Mifepristone also makes the uterine muscle far more sensitive to prostaglandins, which is exactly why the standard protocol adds misoprostol (a synthetic prostaglandin) a day or two later. The second drug triggers strong contractions that expel the pregnancy tissue. Without it, the uterus contracts only moderately after mifepristone, and whether that is enough to finish the job depends on the dose of mifepristone, the gestational age, and individual biology.

How Often Mifepristone Alone Completes an Abortion

The numbers here span a surprisingly wide range. A systematic review of studies where women received mifepristone but not misoprostol found that the proportion of pregnancies that continued one to two weeks later ranged from about 8% to 46%, with lower doses and later gestational ages making continuation more likely.¹ Flipping those numbers around, that means somewhere between roughly half and nine out of ten pregnancies ended with mifepristone alone, depending on the circumstances.

An early clinical trial using a higher single dose of mifepristone (600 mg rather than the 200 mg now standard in most countries) reported complete abortion in about 87% of patients with few side effects.² That result comes from a time when researchers were still testing whether mifepristone alone could work as a standalone method. The medical community ultimately concluded that adding misoprostol pushed success rates above 95%, which is why the two-drug combination became the worldwide standard.

So the honest answer is that mifepristone alone does complete many abortions, but reliably enough is a different question. The uncertainty is the whole reason the second drug exists.

What You Will Physically Experience

Most people feel relatively little in the first few hours after taking mifepristone. The drug does not trigger immediate heavy cramping or bleeding the way misoprostol does. What you may notice in the first day or two includes mild cramping, light spotting, nausea, fatigue, or a headache. Some people feel nothing at all.

If mifepristone does initiate a complete abortion on its own, bleeding and cramping will gradually intensify over the next several days, sometimes resembling a heavy period and sometimes producing clots. This process tends to be slower and less dramatic than it would be with misoprostol added, because the uterus is contracting on its own rather than being driven by prostaglandins.³

If the pregnancy does not end, spotting may taper off and stop. Some people interpret the lack of heavy bleeding as a sign that the mifepristone did not work, but that is not always accurate. Light bleeding followed by nothing can mean the pregnancy is continuing, or it can mean the process stalled midway, leaving tissue behind that has partially detached but not been expelled. This ambiguity is one of the main risks of taking mifepristone without misoprostol.

The Problem of Incomplete Abortion

An incomplete abortion means some pregnancy tissue has been expelled but not all of it. This is the outcome that clinicians worry about most in mifepristone-only scenarios. The uterine lining has broken down, blood supply to the embryo has been disrupted, but the tissue remains partially inside the uterus. Retained tissue can cause prolonged heavy bleeding, infection, and in rare cases serious illness.

When the two-drug regimen works as intended, misoprostol’s strong contractions largely clear the uterus. Without that push, the chance of retained tissue goes up, though no large trial has precisely quantified how much higher the risk is for mifepristone-only cases versus the combined regimen. Clinical guidelines treat an incomplete abortion as a situation that needs medical attention, usually either a course of misoprostol given later or a procedural intervention to remove the tissue.

One way clinicians track whether an abortion is complete is by monitoring a hormone called hCG, the same hormone measured by home pregnancy tests. A recent study of early medication abortions found that a decline in hCG of 80% or more within about a week reliably confirmed complete abortion and ruled out ectopic or ongoing pregnancies.⁴ If you have taken mifepristone alone and are unsure about the outcome, an hCG blood test several days later is one of the clearest tools available.

What If the Pregnancy Continues

This is probably the question that causes the most anxiety. If mifepristone does not end the pregnancy and you decide to continue it, does the drug harm the fetus?

The best evidence so far is cautiously reassuring, with caveats. A prospective observational study following pregnancies that continued after first-trimester mifepristone exposure found a rate of major congenital malformations of about 4.2%, compared to the expected background rate of 2-3% in the general population. The researchers described the data as “reassuring” given the small sample size and the fact that the difference was modest.⁵ A more recent systematic review reached a similar conclusion, finding that while anomalies were observed in some mifepristone-exposed pregnancies, many of those cases had other explanations, and the review did not find evidence to classify mifepristone as a teratogen.⁶

However, another systematic review and meta-analysis took a more cautious position, concluding that a potential teratogenic effect of mifepristone during pregnancy “cannot be ruled out.”⁷ The tension between these conclusions reflects the reality that the studies are small, follow-up is difficult, and the kind of large randomized trial that would settle the question is neither practical nor ethical to conduct. What you can reasonably take from the combined evidence is that mifepristone exposure does not appear to cause birth defects at a dramatically elevated rate, but the data is thin enough that researchers cannot say the risk is zero.

If you have taken mifepristone and want to continue the pregnancy, the most important step is getting an ultrasound to confirm viability and then having close prenatal follow-up.

The “Abortion Reversal” Controversy

You may have heard claims that the effects of mifepristone can be reversed by taking progesterone shortly afterward. This idea has become politically charged, with several U.S. states passing laws requiring doctors to inform patients about “abortion reversal” before prescribing mifepristone. The scientific evidence behind the claim is thin and contested.

A systematic review examined available data on progesterone supplementation after mifepristone. Among 561 individuals who received progesterone after mifepristone, about 48% had ongoing pregnancies. For those at seven weeks of gestation or earlier, the ongoing pregnancy rate was about 42% with progesterone compared to roughly 22% with mifepristone alone. At seven to eight weeks, the rates were closer together: about 62% with progesterone versus 50% with mifepristone alone.⁸ The review rated the quality of evidence as low, largely because it came from case series with serious methodological problems. The one randomized trial that attempted to test the approach was halted early because participants in both the progesterone and placebo groups experienced heavy bleeding events.

A separate scoping review concluded that about two-thirds of women who received progesterone after mifepristone were able to continue their pregnancies, framing the intervention as safe and effective.⁹ That conclusion, however, rests on uncontrolled data. Because mifepristone alone fails to end a significant fraction of pregnancies anyway, some of those “successful reversals” may simply be pregnancies that would have continued without any intervention. Without well-controlled trials, it is impossible to separate the effect of progesterone from the natural failure rate of mifepristone as a standalone drug. Major medical organizations have not endorsed “abortion reversal” as a proven treatment, and the safety data on administering high-dose progesterone in this context remains limited.

Why the Timing Between Mifepristone and Misoprostol Matters

If you have taken mifepristone and plan to follow through with misoprostol, how long you wait between the two drugs affects the outcome. In a large randomized trial comparing a 24-hour interval to the traditional 48-hour interval for abortions between 9 and 20 weeks, the group that waited 48 hours had a slightly higher successful abortion rate within 12 hours: about 94% versus 89% for the 24-hour group.¹⁰ This is consistent with the understanding that mifepristone needs time to fully block progesterone receptors and sensitize the uterus to prostaglandins before misoprostol can do its job most effectively.

In practice, this means that if you have taken mifepristone and it has been less than 48 hours, misoprostol is still a viable and expected next step. Delaying beyond 48 hours is generally not recommended unless a provider advises otherwise, but the combined regimen still works at various intervals. The key point is that taking mifepristone does not lock you into a narrow window. You have time to decide what comes next, and clinical guidance remains available throughout.

Scenarios That Lead People to Take Mifepristone Alone

It is worth acknowledging why this question comes up so often. Not everyone who takes mifepristone alone does so intentionally. Some people receive mifepristone at a clinic and are given misoprostol to take at home later, then experience a change in circumstances, fear, or a change of heart. Others have difficulty accessing or affording the second medication. In some cases, nausea causes the misoprostol to be vomited up before it takes effect. Each of these situations produces a different emotional and medical reality, but the physiological question is the same: the process has been started, and the body is somewhere between the beginning and end of it.

There is no medical emergency inherent in having taken only mifepristone. The drug itself does not put you in immediate danger. But the situation does need resolution, because the three possible outcomes (complete abortion, incomplete abortion, and continuing pregnancy) each require different next steps. If you are in this situation, contacting a healthcare provider or an abortion hotline is the most practical thing you can do. They can help you determine where things stand and decide how to proceed based on your goals.

Mifepristone Beyond Abortion

The question in the title is almost always about medication abortion, but mifepristone has a separate medical identity that sheds light on how the drug behaves at different doses and over different time frames. At ultra-low doses (2.5 mg per day or less, compared to the 200 mg single dose used in abortion), mifepristone has been used to manage uterine fibroids. A case report documented a patient who took ultra-low-dose mifepristone daily from age 50 to 54 and successfully controlled fibroid growth, maintained a normal menstrual cycle, and saw improvement in anemia symptoms. After several years of use, a biopsy found no endometrial abnormalities.¹¹

Mifepristone is also FDA-approved for treating Cushing syndrome, where cortisol levels are dangerously high. In that context, the drug is given at much higher doses than in abortion, and the side effect profile is different. Clinicians managing Cushing patients on mifepristone monitor for effects like low potassium, changes in thyroid function, rash, and symptoms of cortisol withdrawal.¹² These side effects are largely irrelevant to someone who took a single 200 mg dose for abortion purposes, but they illustrate that mifepristone’s behavior depends heavily on dose and duration. A one-time dose that blocks progesterone for a few days is a fundamentally different pharmacological event than months of daily dosing at higher levels.

Research into mifepristone’s effects on the uterine lining has also noted that chronic use at low doses can cause characteristic changes in endometrial tissue, including cystic glandular features that can look concerning under a microscope even when they are benign.¹³ For the person who took a single dose and is wondering what happens next, these findings are not directly relevant. But they do underline a broader point: mifepristone is a powerful and well-studied drug with a safety profile that shifts depending on how it is used.